Sanofi-Aventis Avapro Product Recall(2021-06-14)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. Avapro 75mg
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| ET04153, FT01995, FT01238 | - Recalling Firm
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
- Marketing Authorization Holder
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
| B. Avapro 150mg | DIN 02237924 | Tablet | Irbesartan 150 mg |
| FT00969, FT01225, FT01226, FT01999, FT04262 | - Recalling Firm
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
- Marketing Authorization Holder
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
| C. Avapro 300mg | DIN 02237925 | Tablet | Irbesartan 300 mg |
| FT00590 | - Recalling Firm
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
- Marketing Authorization Holder
- Sanofi-Aventis Canada Inc.
- 2905 Place Louis.R-Renaud
- Laval
- H7V 0A3
- Quebec
- CANADA
| A. Avapro 75mg | DIN 02237923 | Tablet | Irbesartan 75 mg |
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration
limit in affected lot.
Retailers, Other (healthcare practioners)